Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 24 is a human nuclear pseudogene derived from mitochondrial DNA, representing a non-functional copy of the MT-ND5 gene. MT-ND5 itself encodes a core subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase) that is crucial for electron transport and ATP synthesis through oxidative phosphorylation[1][3][5][6][7][8]. However, MTND5P24 does not encode a functional protein product; it carries mutations and disruptions that prevent translation into a functional subunit[6]. The designation "pseudogene" indicates the sequence is a genomic relic and not an active molecular target for therapeutics or drug interactions. Variants of the functional MT-ND5 gene are associated with mitochondrial diseases, but the pseudogene MTND5P24 has no established biological or disease function. The name "MT-ND5 pseudogene 24" refers to a nuclear pseudogene, not the active mitochondrial MT-ND5 gene or protein. The active MT-ND5 gene (not the pseudogene) is involved in mitochondrial electron transport, and mutations in the authentic gene are linked to diseases like Leigh syndrome, MELAS, and Leber hereditary optic neuropathy[1][3][5][8]. The pseudogene, however, has no such roles. The query is thus focused on a non-target, and this should be flagged as potentially incorrect for pharmacological or therapeutic target inquiry. MTND5P24 is a non-functional pseudogene, not a valid drug or therapeutic target[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 24 (MTND5P24).